Science
Responsibility
Company
Careers

News Hub

English (EN)
Francais (FR)

Search

News Hub

News Hub

Filters

October 27, 2026

Canadians Living with Primary Biliary Cholangitis (PBC) One Step Closer to New Treatment Option as Gilead Reaches Milestone National Agreement for LYVDELZI® (seladelpar)

Media Contacts

Email: canada_info@gilead.com

For additional contact information, please visit the Contact Us page.

This website is intended for residents of Canada.

INFORMATION

Sitemap
Gilead.com
Product Monographs

GET IN TOUCH

Contact Us
Report an Adverse Event
Medical Information

COUNTRY DISCLOSURES

Cookie Statement
Manage Cookie Settings
Privacy Statement
Healthcare Professional Privacy Notice
Social Media Guidelines
Terms of Use

© 1996-2026 Gilead Sciences, Inc. All rights reserved.

You are now leaving www.gilead.com/en-ca and visiting a third-party website which is not owned or controlled by Gilead Sciences. Links to these sites are provided as a resource to our visitors. Gilead does not assume responsibility for any content on linked sites.

You are now leaving www.gilead.com/en-ca and visiting our global website, Gilead.com. Please note some of the content on this site is only intended for audiences in the United States. 